Unleashing new MTDL AChE and BuChE inhibitors as potential anti-AD therapeutic agents: In vitro, in vivo and in silico studies
Dalia Zaafar, Nehal H. Elghazawy, Afnan Hassan, Mohamed Y. Mahmoud, Alaa F. Bakr, Reem K. Arafa
Topics & Concepts
In silicoIn vivoAcetylcholinesteraseAchéChemistryEx vivoIn vitroPharmacologyButyrylcholinesteraseDocking (animal)BiochemistryEnzymeBiologyMedicineNursingBiotechnologyGeneCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsMedicinal Plants and Neuroprotection